Section 174 R&D amortization remains one of the most consequential tax issues facing U.S. businesses in 2026. Companies that rely on research, product development, or software engineering continue to grapple with mandatory capitalization rules that increase taxable income, reduce cash flow, and complicate long‑term planning. As Congress has not yet reversed the Tax Cuts and Jobs Act (TCJA) changes, understanding Section 174 is essential for compliance and strategic tax management in the 2026 filing season.
What Is Section 174 R&D Amortization?
Section 174 governs how businesses treat research and experimental (R&E) expenditures. Prior to 2022, companies could immediately deduct R&D costs in the year they were incurred. The TCJA changed this rule beginning in 2022, requiring businesses to capitalize and amortize R&D expenses over multiple years.
For the 2026 tax year:
- Domestic R&D costs must be amortized over 5 years
- Foreign R&D costs must be amortized over 15 years
- The midyear convention applies, allowing only half a year of amortization in the first year
These rules significantly increase taxable income for companies with substantial research activities, especially startups, software developers, and technology‑driven businesses.
What Qualifies as Section 174 R&D Expenses?
Section 174 uses a broad definition of research expenditures. Any cost incurred to eliminate uncertainty in product development or improvement may qualify, including:
- Employee wages for engineers, developers, and R&D staff
- Materials and supplies used in research
- Software development costs
- Third‑party research contracts
- Prototype development and testing
- Patent‑related legal fees
- Allocable overhead tied to R&D activities
Because the definition is so broad, many companies—especially those involved in software development—fall under Section 174 even if they do not consider themselves traditional R&D organizations.
Section 174 vs. Section 41: Key Differences in 2026
Businesses often confuse Section 174 with Section 41, the R&D tax credit. While related, they serve different purposes:
- Section 174
- Governs how R&D expenses are deducted
- Requires amortization over 5 or 15 years
- Applies broadly to research and development activities
- Section 41
- Provides a tax credit for qualified research
- Has narrower qualification rules
- Can offset some of the tax burden created by Section 174
Importantly, Section 41 qualified research expenses (QREs) must also be treated as Section 174 costs, making accurate tracking essential.
How Section 174 Amortization Impacts Businesses in 2026
The continued enforcement of Section 174 has several major implications:
1. Higher Taxable Income
Companies lose the ability to deduct R&D costs immediately, increasing taxable income—often substantially.
2. Reduced Cash Flow
Startups and small businesses feel the impact most, as they rely heavily on immediate deductions to manage cash.
3. Increased Accounting Complexity
Businesses must track R&D costs at a granular level, often requiring new systems, documentation processes, and internal controls.
4. Potential Impact on Valuation and Investor Reporting
Higher tax liabilities can affect EBITDA, cash reserves, and financial projections.
Compliance Requirements for 2026
To comply with Section 174, businesses must:
- Identify all R&D activities across departments
- Track costs at the project or product level
- Separate domestic vs. foreign research
- Maintain detailed documentation supporting R&D classification
- Apply amortization schedules consistently
- Update accounting systems to reflect capitalization rules
The IRS continues to emphasize documentation quality, making thorough recordkeeping a critical audit defense.
Strategies to Reduce the Impact of Section 174 in 2026
1. Maximize the R&D Tax Credit
Section 41 credits directly reduce tax liability and can offset payroll taxes for eligible startups.
2. Improve Cost Allocation
Accurate allocation of labor, overhead, and materials prevents over‑capitalization.
3. Reevaluate Foreign Research
Foreign R&D is amortized over 15 years three times longer than domestic research making location planning more important.
4. Implement Project‑Level Tracking
Better tracking ensures only true R&D costs are capitalized.
5. Plan the Timing of Major R&D Investments
Strategic timing can help smooth taxable income fluctuations.
Will Section 174 Change in 2026?
Congress continues to debate restoring immediate expensing for R&D, and bipartisan proposals have been introduced. However, as of the 2026 filing season, mandatory amortization remains in effect, and businesses must comply until legislative changes occur.
Why Section 174 Matters in 2026
With ongoing enforcement, increased IRS scrutiny, and rising compliance costs, Section 174 remains a top tax priority for:
- Technology companies
- Software developers
- Manufacturers
- Engineering firms
- Pharmaceutical and biotech companies
- Startups building new products or platforms
Understanding the rules and planning around them is essential for minimizing tax exposure and maintaining financial stability in 2026.
Final Thoughts
Section 174 R&D amortization continues to reshape how businesses handle research costs in 2026. While the rules create challenges, companies that invest in documentation, tax planning, and credit optimization can reduce the financial impact and stay compliant. Until Congress acts, proactive planning remains the best strategy for navigating Section 174 in the 2026 tax year.
This article provides information only and should not be construed as advice. It is provided without warranty of any kind.